Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
Targeted therapy based on natural compounds is one of the best approaches against non-small cell lung cancer. Ursolic acid (UA), a pentacyclic triterpenoid derived from medicinal herbs, has anticancer activity. Studies on the molecular mechanism underlying UA’s anticancer activity are ongoing. Here,...
Main Authors: | Dong Young Kang, Nipin Sp, Jin-Moo Lee, Kyoung-Jin Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/3/297 |
Similar Items
-
Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells
by: Alexis Rugamba, et al.
Published: (2021-06-01) -
Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
by: Xiaona Xie, et al.
Published: (2021-08-01) -
Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
by: Zhucheng Zhao, et al.
Published: (2022-11-01) -
Cytochalasin H enhances sensitivity to gefitinib in non-small-cell lung cancer cells through inhibiting EGFR activation and PD-L1 expression
by: Guihong Zhang, et al.
Published: (2024-10-01) -
Ursolic Acid Protects Sodium Dodecyl Sulfate-Induced <i>Drosophila</i> Ulcerative Colitis Model by Inhibiting the JNK Signaling
by: Tian Wei, et al.
Published: (2022-02-01)